Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Eurotrans opened the first exchange offer window

4/19/24 EUTR

MTS Bank started collecting applications for participation in IPO

4/19/24 MBNK

Board of Directors of TMK recommended that dividends be paid for 2023

4/19/24 TRMK

Astra has clarified the price of the share placement

4/18/24 ASTR

Polyus and Polymetal will jointly conduct geological exploration of Lyuginskaya area

4/18/24 PLZL

Slavneft-Megionneftegaz reported for 3 months of 2024 by RAS

4/18/24 MFGS

Himprom reported for 2024 by RAS

4/18/24 HIMCP

VSMPO-AVISMA reported for 3 months in 2024 by RAS

4/18/24 VSMO

Cherkizovo reported for 3 months of 2024 by RAS

4/18/24 GCHE

Mosenergo in Q1 increased electricity generation by 3.8%

4/18/24 MSNG